维普中文期刊产品整合服务
48篇 您的检索式:作者名="Abildgaard U"
    题名 作者 年代 出处 被引量
1Elevated plasma levels of the factor Xa-TFPI complex in cancer patients显示文摘 Lindahl AK Abildgaard U 2002Thromb Res2002,105,1:1
2The HELLP syndrome: clinical issues and management 显示文摘HARAM K SVENDSEN E ABILDGAARD U 2009BMC Pregnancy Childbirth2009,9,:1
3The HELLP syndrome: clinical issues and management显示文摘Haramk svendsen E Abildgaard U 2009BMC pregnancy childbirth2009,9,:1
4A sensitive assay of sic extrinsic coagualation pathway inhibitor(EPI)in plasma fractions显示文摘 Abildgaard U Pettersen M 1987Thromb Res1987,47,4:1
5The transplanted human kidney does not achieve functional reinnervation显示文摘Hansen JM Abildgaard U Fogh-Andersen N 0,,:1
6The effect of antithrombin III on the activity of the coagulation factors VII, IX and X显示文摘Osterud B Miller-Andersson M Abildgaard U 1976Thromb Haemost1976,35,2:1
7HGF inhibits BMP-induced osteoblastogenesis:possible implications for the bone disease of multiple myeloma显示文摘Standal T Abildgaard N Fagerli U M 2007Blood2007,109,7:1
8A sensitive assay of extrinsic coag ulation pathway inhibitor(EPI) in plasma and plasma fractions显示文摘 Abildgaard U Pettersen M 1987Thromb Res1987,47,:1
9Intracoro- nary compared to intravenous bolus abciximab during primary per- cutaneous coronary intervention in ST-segment elevation myocar- dial infarction (STEMI) patients reduces 30-day mortality and target vessel revaseularization : a randomized trial 显示文摘IYERSEN A ABILDGAARD U GALLOE A 2011J lnterven Cardiol2011,24,2:1
10Intracoronary compared to intravenous bolus abciximab during primary percutaneous coro- nary intervention in ST-segment elevation myocardial infarction (STEMI) patients reduces 30-day mortality and target vessel re- vascularization : a randomized trial 显示文摘Iversen A Abildgaard U Galloe A 2011J Interven Cardiol2011,24,3:1
11A sensitive assay of extrinsic coagulation pathway inhibitor in plasma and plasma fraction显示文摘Sandet PM Abildgaard U Putersen MJ 1987Thromb Res1987,47,2:1
12Antithrombin -early prophecies and present challenges 显示文摘Abildgaard U 2007Thromb Haemost2007,98,:1
13Intraeor- onary compared to intravenous abciximab in patients with ST seg- ment elevation myocardial infarction treated with primary percuta- neous coronary intervention reduces mortality, target vessel revas- cularization and reinfarction after 1 year 显示文摘IVERSEN AZ GALATIUS S ABILDGAARD U 2011Cardiology2011,120,1:1
14Increased plasma thrombomdulin in cancer patients显示文摘 Boffa MC Abildgaard U 1993Thromb Haemost1993,69,:1
15Intracoronarycom pared to intravenous abciximab in patients withST segment eleva- tion myocardial infarction treated withprimary percutaneous coro- nary intervention reduces mortality, target vessel revascularization and reinfaretion afterl yearl显示文摘Iversen AZ Galatius S Abildgaard U 2011Cardiology2011,120,1:1
16HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma显示文摘Standal T Abildgaard N Fagerli U M 2007Blood2007,109,7:1
17A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions显示文摘Sandset PM Abildgaard U Pettersen M 1987Thromb Res1987,47,4:1
18Intracoronary compared to intravenous abciximab in patients with ST segment elevation myocardial infarction treated with primary percutane- ous coronary intervention reduces mortality, target vessel revas- cularization and reinfarction after 1 year 显示文摘Iversen AZ Galatius S Abildgaard U 2011Cardiology2011,120,1:1
19Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary in- tervention in ST-segment Elevation Myocardial Infarction (STEMI) pa- tients reduces 30-day mortality and target vessel revascularization: a randomized trial 显示文摘Iversen A Abildgaard U Galloe A 2011J Interv Cardiol2011,24,2:1
20Increased plasma thrombomodulin in cancer patients显示文摘LINDAHL A K BOFFA M C ABILDGAARD U 1993Thromb Hae most1993,69,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费